Product References
A three-protein biomarker panel assessed in diagnostic tissue predicts death from prostate cancer for men with localized disease.
Cancer medicine
Severi G,FitzGerald LM,Muller DC,Pedersen J,Longano A,Southey MC,Hopper JL,English DR,Giles GG,Mills J
35-9700 was used in immunohistochemistry to investigate the prognostic significance of a three-protein biomarker panel for prostate cancer
Wed Oct 01 00:00:00 UTC 2014
Systems analysis of the prostate tumor suppressor NKX3.1 supports roles in DNA repair and luminal cell differentiation.
F1000Research
Yang CC,Chung A,Ku CY,Brill LM,Williams R,Wolf DA
35-9700 was used in western blot to study the roles of prostate tumor suppressor NKX3.1 in DNA repair and luminal cell differentiation
Fri Sep 16 00:00:00 UTC 2016
Systems analysis of the prostate tumor suppressor NKX3.1 supports roles in DNA repair and luminal cell differentiation.
F1000Research
Yang CC,Chung A,Ku CY,Brill LM,Williams R,Wolf DA
35-9700 was used in western blot to study the roles of prostate tumor suppressor NKX3.1 in DNA repair and luminal cell differentiation
Fri Sep 16 00:00:00 UTC 2016
TWIST1, A novel androgen-regulated gene, is a target for NKX3-1 in prostate cancer cells.
Cancer cell international
Eide T,Ramberg H,Glackin C,Tindall D,Taskén KA
35-9700 was used in chip-sequencing to elucidate the metastatic process.
Thu Jan 31 00:00:00 UTC 2013
NKX3.1 homeodomain protein binds to topoisomerase I and enhances its activity.
Cancer research
Bowen C,Stuart A,Ju JH,Tuan J,Blonder J,Conrads TP,Veenstra TD,Gelmann EP
Mon Jan 15 00:00:00 UTC 2007
NKX3.1 homeodomain protein binds to topoisomerase I and enhances its activity.
Cancer research
Bowen C,Stuart A,Ju JH,Tuan J,Blonder J,Conrads TP,Veenstra TD,Gelmann EP
Mon Jan 15 00:00:00 UTC 2007